GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness

Somatic and germline mutations in the dual zinc-finger transcription factor GATA3 are associated with breast cancers expressing the estrogen receptor (ER) and the autosomal dominant hypoparathyroidism-deafness-renal dysplasia syndrome, respectively. To elucidate the role of GATA3 in breast tumorigen...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Gaynor, K, Grigorieva, I, Allen, MD, Esapa, C, Head, R, Gopinath, P, Christie, P, Nesbit, M, Jones, J, Thakker, R
פורמט: Journal article
שפה:English
יצא לאור: 2013
_version_ 1826294858643406848
author Gaynor, K
Grigorieva, I
Allen, MD
Esapa, C
Head, R
Gopinath, P
Christie, P
Nesbit, M
Jones, J
Thakker, R
author_facet Gaynor, K
Grigorieva, I
Allen, MD
Esapa, C
Head, R
Gopinath, P
Christie, P
Nesbit, M
Jones, J
Thakker, R
author_sort Gaynor, K
collection OXFORD
description Somatic and germline mutations in the dual zinc-finger transcription factor GATA3 are associated with breast cancers expressing the estrogen receptor (ER) and the autosomal dominant hypoparathyroidism-deafness-renal dysplasia syndrome, respectively. To elucidate the role of GATA3 in breast tumorigenesis, we investigated 40 breast cancers that expressed ER, for GATA3 mutations. Six different heterozygous GATA3 somatic mutations were identified in eight tumors, and these consisted of: a frameshifting deletion/insertion (944_945delGGinsAGC), an in-frame deletion of a key arginine residue (991_993delAGG), a seven-nucleotide frameshifting insertion (991_992insTGGAGGA), a frameshifting deletion (1196_1197delGA), and two frameshifting single nucleotide insertions (1224_1225insG found in three tumors and 1224_1225insA). Five of the eight mutations occurred in tumors that retained GATA3 immunostaining, indicating that absence of GATA3 immunostaining is an unreliable predictor of the presence of GATA3 mutations. Luciferase reporter assays, electrophoretic mobility shift assays, immunofluorescence, invasion and proliferation assays demonstrated that the GATA3 mutations resulted in loss (or reduction) of DNA binding, decrease in transactivational activity, and alterations in invasiveness but not proliferation. The 991_992insTGGAGGA (Arg330 frameshift) mutation led to a loss of nuclear localization, yet the 991_993delAGG (Arg330deletion) retained nuclear localization. Investigation of the putative nuclear localization signal (NLS) sites showed that the NLS of GATA3 does not conform to either a classical mono- or bi-partite signal, but contains multiple cooperative NLS elements residing around the N-terminal zinc-finger which comprises residues 264-288. Thus, approximately 20 % ER-positive breast cancers have somatic GATA3 mutations that lead to a loss of GATA3 transactivation activity and altered cell invasiveness. © 2013 Springer Science+Business Media New York.
first_indexed 2024-03-07T03:52:10Z
format Journal article
id oxford-uuid:c1a6eb8c-6e01-4910-8c1f-938d4e211c0a
institution University of Oxford
language English
last_indexed 2024-03-07T03:52:10Z
publishDate 2013
record_format dspace
spelling oxford-uuid:c1a6eb8c-6e01-4910-8c1f-938d4e211c0a2022-03-27T06:03:07ZGATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell InvasivenessJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c1a6eb8c-6e01-4910-8c1f-938d4e211c0aEnglishSymplectic Elements at Oxford2013Gaynor, KGrigorieva, IAllen, MDEsapa, CHead, RGopinath, PChristie, PNesbit, MJones, JThakker, RSomatic and germline mutations in the dual zinc-finger transcription factor GATA3 are associated with breast cancers expressing the estrogen receptor (ER) and the autosomal dominant hypoparathyroidism-deafness-renal dysplasia syndrome, respectively. To elucidate the role of GATA3 in breast tumorigenesis, we investigated 40 breast cancers that expressed ER, for GATA3 mutations. Six different heterozygous GATA3 somatic mutations were identified in eight tumors, and these consisted of: a frameshifting deletion/insertion (944_945delGGinsAGC), an in-frame deletion of a key arginine residue (991_993delAGG), a seven-nucleotide frameshifting insertion (991_992insTGGAGGA), a frameshifting deletion (1196_1197delGA), and two frameshifting single nucleotide insertions (1224_1225insG found in three tumors and 1224_1225insA). Five of the eight mutations occurred in tumors that retained GATA3 immunostaining, indicating that absence of GATA3 immunostaining is an unreliable predictor of the presence of GATA3 mutations. Luciferase reporter assays, electrophoretic mobility shift assays, immunofluorescence, invasion and proliferation assays demonstrated that the GATA3 mutations resulted in loss (or reduction) of DNA binding, decrease in transactivational activity, and alterations in invasiveness but not proliferation. The 991_992insTGGAGGA (Arg330 frameshift) mutation led to a loss of nuclear localization, yet the 991_993delAGG (Arg330deletion) retained nuclear localization. Investigation of the putative nuclear localization signal (NLS) sites showed that the NLS of GATA3 does not conform to either a classical mono- or bi-partite signal, but contains multiple cooperative NLS elements residing around the N-terminal zinc-finger which comprises residues 264-288. Thus, approximately 20 % ER-positive breast cancers have somatic GATA3 mutations that lead to a loss of GATA3 transactivation activity and altered cell invasiveness. © 2013 Springer Science+Business Media New York.
spellingShingle Gaynor, K
Grigorieva, I
Allen, MD
Esapa, C
Head, R
Gopinath, P
Christie, P
Nesbit, M
Jones, J
Thakker, R
GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness
title GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness
title_full GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness
title_fullStr GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness
title_full_unstemmed GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness
title_short GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness
title_sort gata3 mutations found in breast cancers may be associated with aberrant nuclear localization reduced transactivation and cell invasiveness
work_keys_str_mv AT gaynork gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT grigorievai gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT allenmd gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT esapac gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT headr gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT gopinathp gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT christiep gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT nesbitm gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT jonesj gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness
AT thakkerr gata3mutationsfoundinbreastcancersmaybeassociatedwithaberrantnuclearlocalizationreducedtransactivationandcellinvasiveness